We are live on ! Find out more
Brown Advisory

Brown Advisory Portfolio holdings

AUM $60.9B
1-Year Est. Return 15.24%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$39.4B
AUM Growth
+$3.78B
Cap. Flow
+$934M
Cap. Flow %
2.37%
Top 10 Hldgs %
22.56%
Holding
1,080
New
75
Increased
361
Reduced
442
Closed
44

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$242M
2
ILMN icon
Illumina
ILMN
+$98.3M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$80.6M
4
AMZN icon
Amazon
AMZN
+$63.7M
5
FTV icon
Fortive
FTV
+$55.5M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$61.6M
2
MTD icon
Mettler-Toledo International
MTD
+$54.4M
3
EW icon
Edwards Lifesciences
EW
+$47.2M
4
DHR icon
Danaher
DHR
+$46.2M
5
MSFT icon
Microsoft
MSFT
+$45.4M

Sector Composition

Rank Sector Weight
1 Technology 22.67%
2 Healthcare 17.29%
3 Financials 13.57%
4 Consumer Discretionary 12.51%
5 Industrials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQR icon
951
Equity Residential
EQR
$25.4B
$225K ﹤0.01%
2,786
-3,297
-54% -$281K
LUMN icon
952
Lumen
LUMN
$6.53B
$225K ﹤0.01%
17,093
+6,221
+57% +$83.4K
RGEN icon
953
Repligen
RGEN
$7.44B
$225K ﹤0.01%
+2,438
New +$205K
OMCL icon
954
Omnicell
OMCL
$1.86B
$224K ﹤0.01%
+2,748
New +$211K
IPHS
955
DELISTED
Innophos Holdings, Inc.
IPHS
$224K ﹤0.01%
7,000
CSWC icon
956
Capital Southwest
CSWC
$1.46B
$223K ﹤0.01%
10,700
VRTX icon
957
Vertex Pharmaceuticals
VRTX
$121B
$223K ﹤0.01%
+1,020
New +$206K
FXI icon
958
iShares China Large-Cap ETF
FXI
$4.31B
$222K ﹤0.01%
5,111
OGS icon
959
ONE Gas
OGS
$5.05B
$222K ﹤0.01%
2,366
XRAY icon
960
Dentsply Sirona
XRAY
$2.59B
$220K ﹤0.01%
3,883
FIVN icon
961
FIVE9
FIVN
$1.77B
$219K ﹤0.01%
+3,341
New +$204K
PRFZ icon
962
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.75B
$218K ﹤0.01%
7,985
TDY icon
963
Teledyne Technologies
TDY
$30.4B
$218K ﹤0.01%
629
-42
-6% -$14.1K
HR icon
964
Healthcare Realty
HR
$7.42B
$217K ﹤0.01%
7,160
SR icon
965
Spire
SR
$4.92B
$217K ﹤0.01%
2,600
BCO icon
966
Brink's
BCO
$5.02B
$215K ﹤0.01%
+2,376
New +$210K
DBEF icon
967
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.13B
$215K ﹤0.01%
6,346
+116
+2% +$3.85K
VIAV icon
968
Viavi Solutions
VIAV
$9.75B
$214K ﹤0.01%
+14,255
New +$213K
IVAL icon
969
Alpha Architect International Quantitative Value ETF
IVAL
$214M
$213K ﹤0.01%
+7,218
New +$207K
SMPL icon
970
Simply Good Foods
SMPL
$904M
$213K ﹤0.01%
+7,494
New +$198K
BY icon
971
Byline Bancorp
BY
$1.75B
$211K ﹤0.01%
10,769
IYE icon
972
iShares US Energy ETF
IYE
$1.74B
$211K ﹤0.01%
6,560
NOV icon
973
NOV
NOV
$7.45B
$211K ﹤0.01%
+8,416
New +$189K
DPZ icon
974
Domino's
DPZ
$11B
$210K ﹤0.01%
+715
New +$197K
RWJ icon
975
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.03B
$210K ﹤0.01%
+9,240
New +$202K

Similar funds

Brown Advisory's Q4 2019 Portfolio in Review

As of Q4 2019, Brown Advisory held 1,080 positions worth $39.4B, up 11% from $35.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Brown Advisory's Q4 2019 filing shows 75 new, 361 increased, 442 reduced and 44 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 228,512 shares worth $84.6M. The largest sale was PayPal, an estimated $61.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Brown Advisory's largest Q4 2019 buy was Bio-Rad Laboratories Class A: 228,512 shares worth $84.6M.
  • Brown Advisory added most to L3Harris in Q4 2019, an estimated $242M increase.
  • Brown Advisory's biggest Q4 2019 reduction was PayPal, cutting an estimated $61.6M.
  • Brown Advisory fully exited Loral Space and Communications, Inc. in Q4 2019, selling an estimated $21.1M.
  • Brown Advisory's ten largest holdings make up 23% of its $39.4B portfolio in Q4 2019.
  • Brown Advisory opened 75 new positions and closed 44 in Q4 2019.
  • Brown Advisory's portfolio value rose 11% quarter-over-quarter to $39.4B.

Based on Brown Advisory's 13F filing for Q4 2019, filed 14 Feb 2020.